Praxis Precision Medicines to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 19, 2026, and Participate in Upcoming Investor Conferences Feb 9, 2026 04:01PM
Praxis Precision Medicines prices $575 million public offering at $260 per share Jan 6, 2026 11:15PM
Praxis Precision Medicines, Inc. Announces Pricing of $575 Million Public Offering Jan 6, 2026 11:15PM
Praxis Precision Medicines announces proposed public stock offering Jan 6, 2026 04:04PM
Praxis Precision Medicines, Inc. Announces Proposed Public Offering Jan 6, 2026 04:03PM


Jan 2, 2026 08:56AM TD Cowen Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Dec 31, 2025 07:16AM TD Cowen: 'We view yesterday's announcement as highly positive for PRAX'
Dec 8, 2025 09:18AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $353 at TD Cowen
Nov 24, 2025 09:06AM TD Cowen on Praxis Precision Medicines Inc. (PRAX): 'Sensitivity Analyses Robust & Supportive Of Topline'
Oct 16, 2025 11:45PM Praxis Precision Medicines prices $525 million stock offering
Oct 16, 2025 11:45PM Praxis Precision Medicines, Inc. Announces Pricing of $525 Million Public Offering
Oct 16, 2025 04:01PM Praxis Precision Medicines announces proposed public offering
Oct 16, 2025 04:01PM Praxis Precision Medicines, Inc. Announces Proposed Public Offering
Oct 16, 2025 12:25PM Praxis Precision Medicines Inc. (PRAX) PT Raised to $251 at TD Cowen as Ph3 ET Ulixa Studies Meet Primary
Sep 4, 2025 04:01PM Praxis Precision Medicines to Participate in September Investor Conferences
Aug 29, 2025 08:00AM Praxis Precision Medicines to Participate in Upcoming Fireside Chat
Aug 4, 2025 02:10PM TD Cowen Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Mar 4, 2025 08:00AM Praxis Precision Medicines to Participate in Five Upcoming Investor Conferences
Feb 28, 2025 03:02PM Praxis Precision Medicines Inc. (PRAX) PT Lowered to $61 at TD Cowen
Sep 24, 2024 08:39AM TD Cowen Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Sep 3, 2024 02:56PM TD Cowen Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Mar 1, 2024 08:00AM Praxis Precision Medicines to Participate in TD Cowen’s 44th Annual Health Care Conference
Mar 3, 2023 04:05PM Praxis Precision Medicines to Present at Upcoming Investor Conferences
Jun 6, 2022 06:09AM PRAX-114 Has "Good Probability of Success and Upside" - Cowen Bullish on Praxis Precision Medicines (PRAX) Ahead of Upcoming Data Readout
Mar 1, 2022 09:00AM Praxis Precision Medicines to Present at Cowen’s 42nd Annual Healthcare Conference
Jul 6, 2021 09:00AM Praxis Precision Medicines to Present at Upcoming Investor Conferences
May 14, 2021 06:02AM Praxis Precision Medicines (PRAX) Prices 5M Share Common Offering at $18.25/Sh
May 13, 2021 10:39PM Praxis Precision Medicines Prices Public Offering of Common Stock
May 11, 2021 04:25PM Praxis Precision Medicines (PRAX) Announces 4M Share Proposed Public Offering of Common Stock
May 11, 2021 04:22PM Praxis Precision Medicines Announces Proposed Public Offering of Common Stock
Oct 20, 2020 04:05PM Praxis Precision Medicines Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
Oct 16, 2020 11:39AM Praxis Precision Medicines (PRAX) IPO Opens 37% Higher
Oct 16, 2020 05:52AM Praxis Precision Medicines, Inc. (PRAX) Prices 10M Share Upsized IPO at $19/Sh
Oct 15, 2020 09:59PM Praxis Precision Medicines Announces Pricing of Upsized Initial Public Offering
Oct 15, 2020 09:58PM Praxis Precision Medicines Announces Pricing of Upsized Initial Public Offering